Nomura's Top Picks: Hindustan Unilever, Lupin, and Anant Raj for Up to 21% Upside Potential
ByAinvest
Tuesday, Sep 30, 2025 4:47 am ET1min read
UL--
Hindustan Unilever, a consumer goods giant, has been given a 'Buy' rating with a target price of Rs 2,900, translating to an estimated 15% upside. Nomura attributes this recommendation to the company's expected normalized standalone/consolidated sales growth of 3%/4% YoY, despite the temporary impact of GST announcements in September [1]. The brokerage expects a recovery in demand from November as prices stabilize.
Lupin, a pharmaceutical company, has also been rated 'Buy' by Nomura with a target price of Rs 2,350, indicating an upside of approximately 21%. The brokerage highlights Lupin's strategic acquisition of VISUfarma, a specialty ophthalmology company in Europe, as a significant growth driver. This move is expected to boost Lupin's presence in a branded and relatively stable segment, with the European ophthalmology market growing at around 5% annually and VISUfarma expected to grow at 7% CAGR over the next three years [1].
Anant Raj, a data center company, is the third pick with a target price of Rs 700, suggesting a 3% upside. Nomura sees potential in the data center segment, noting the company's early start and relatively lower capex costs. The brokerage expects Anant Raj to lease 24 MW of capacity for colocation and 1–2 MW for cloud clients, with targeted FY26 revenue from the segment around Rs 150–200 crore [1].
These recommendations reflect Nomura's optimism about the growth prospects of these companies in their respective sectors. Investors should carefully consider these recommendations along with their own financial goals and risk tolerance.
Nomura recommends three "Buy" stocks: Hindustan Unilever, Lupin, and Anant Raj. Hindustan Unilever has a target price of Rs 2,900, with a 15% upside potential, while Lupin's target price is Rs 2,350, with a 21% upside potential. Anant Raj's target price is Rs 700, with a 3% upside potential. The brokerage firm expects strong returns from these stocks due to their potential growth in their respective sectors.
In a recent report, Nomura has recommended three stocks—Hindustan Unilever, Lupin, and Anant Raj—for investors looking to capitalize on potential growth opportunities. The brokerage firm expects these stocks to deliver strong returns, with upside potential ranging from 3% to 21%.Hindustan Unilever, a consumer goods giant, has been given a 'Buy' rating with a target price of Rs 2,900, translating to an estimated 15% upside. Nomura attributes this recommendation to the company's expected normalized standalone/consolidated sales growth of 3%/4% YoY, despite the temporary impact of GST announcements in September [1]. The brokerage expects a recovery in demand from November as prices stabilize.
Lupin, a pharmaceutical company, has also been rated 'Buy' by Nomura with a target price of Rs 2,350, indicating an upside of approximately 21%. The brokerage highlights Lupin's strategic acquisition of VISUfarma, a specialty ophthalmology company in Europe, as a significant growth driver. This move is expected to boost Lupin's presence in a branded and relatively stable segment, with the European ophthalmology market growing at around 5% annually and VISUfarma expected to grow at 7% CAGR over the next three years [1].
Anant Raj, a data center company, is the third pick with a target price of Rs 700, suggesting a 3% upside. Nomura sees potential in the data center segment, noting the company's early start and relatively lower capex costs. The brokerage expects Anant Raj to lease 24 MW of capacity for colocation and 1–2 MW for cloud clients, with targeted FY26 revenue from the segment around Rs 150–200 crore [1].
These recommendations reflect Nomura's optimism about the growth prospects of these companies in their respective sectors. Investors should carefully consider these recommendations along with their own financial goals and risk tolerance.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet